Literature DB >> 23979726

Decreased expression and role of GRK6 in spinal cord of rats after chronic constriction injury.

Yuan Zhou1, Xiaodong Huang, Hao Wu, Yue Xu, Tao Tao, Guangfei Xu, Chun Cheng, Su Cao.   

Abstract

Nerve injury and inflammation can both induce neuropathic pain via the production of pro-inflammatory cytokines. In the process, G protein-coupled receptors (GPCRs) were involved in pain signal transduction. GPCR kinase (GRK) 6 is a member of the GRK family that regulates agonist-induced desensitization and signaling of GPCRs. However, its expression and function in neuropathic pain have not been reported. In this study, we performed a chronic constriction injury (CCI) model in adult male rats and investigated the dynamic change of GRK6 expression in spinal cord. GRK6 was predominantly expressed in the superficial layers of the lumbar spinal cord dorsal horn neurons and its expression was decreased bilaterally following induction of CCI. The changes of GRK6 were mainly in IB4 and P substrate positive areas in spinal cord dorsal horn. And over-expression of GRK6 in spinal cord by lentivirus intrathecal injection attenuated the pain response induced by CCI. In addition, the level of TNF-α underwent the negative pattern of GRK6 in spinal cord. And neutralized TNF-α by antibody intrathecal injection up-regulated GRK6 expression and attenuated the mechanical allodynia and heat hyperalgesia in CCI model. All the data indicated that down-regulation of neuronal GRK6 expression induced by cytokine may be a potential mechanism that contributes to increasing neuronal signaling in neuropathic pain.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23979726     DOI: 10.1007/s11064-013-1125-x

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  47 in total

1.  An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine.

Authors:  E Milligan; V Zapata; D Schoeniger; M Chacur; P Green; S Poole; D Martin; S F Maier; L R Watkins
Journal:  Eur J Neurosci       Date:  2005-12       Impact factor: 3.386

Review 2.  Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization.

Authors:  J Zhang; S S Ferguson; L S Barak; M J Aber; B Giros; R J Lefkowitz; M G Caron
Journal:  Receptors Channels       Date:  1997

3.  Differential effects of NMDA and group I mGluR antagonists on both nociception and spinal cord protein kinase C translocation in the formalin test and a model of neuropathic pain in rats.

Authors:  Kiran Yashpal; Kim Fisher; Jean-Guy Chabot; Terence J Coderre
Journal:  Pain       Date:  2001-10       Impact factor: 6.961

4.  Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat.

Authors:  A J Reeve; S Patel; A Fox; K Walker; L Urban
Journal:  Eur J Pain       Date:  2000       Impact factor: 3.931

Review 5.  Neuronal plasticity: increasing the gain in pain.

Authors:  C J Woolf; M W Salter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

6.  Granulocyte chemotaxis and disease expression are differentially regulated by GRK subtype in an acute inflammatory arthritis model (K/BxN).

Authors:  Teresa K Tarrant; Rishi R Rampersad; Denise Esserman; Lisa R Rothlein; Peng Liu; Richard T Premont; Robert J Lefkowitz; David M Lee; Dhavalkumar D Patel
Journal:  Clin Immunol       Date:  2008-07-26       Impact factor: 3.969

Review 7.  Neuropathic pain: a maladaptive response of the nervous system to damage.

Authors:  Michael Costigan; Joachim Scholz; Clifford J Woolf
Journal:  Annu Rev Neurosci       Date:  2009       Impact factor: 12.449

8.  G protein-coupled receptor kinase 6 controls post-inflammatory visceral hyperalgesia.

Authors:  Niels Eijkelkamp; Cobi J Heijnen; Sigrid Elsenbruch; Gerald Holtmann; Manfred Schedlowski; Annemieke Kavelaars
Journal:  Brain Behav Immun       Date:  2008-07-22       Impact factor: 7.217

9.  Functional role of exogenous administration of substance P in chronic constriction injury model of neuropathic pain in gerbils.

Authors:  Theo F Meert; Kris Vissers; Frank Geenen; Vesa K Kontinen
Journal:  Pharmacol Biochem Behav       Date:  2003-08       Impact factor: 3.533

10.  Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain.

Authors:  Wei Guo; Hu Wang; Mineo Watanabe; Kohei Shimizu; Shiping Zou; Stacey C LaGraize; Feng Wei; Ronald Dubner; Ke Ren
Journal:  J Neurosci       Date:  2007-05-30       Impact factor: 6.167

View more
  6 in total

1.  Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain.

Authors:  Peishen Zhao; TinaMarie Lieu; Nicholas Barlow; Silvia Sostegni; Silke Haerteis; Christoph Korbmacher; Wolfgang Liedtke; Nestor N Jimenez-Vargas; Stephen J Vanner; Nigel W Bunnett
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

2.  Prognostic value of decreased GRK6 expression in lung adenocarcinoma.

Authors:  Sumei Yao; Lou Zhong; Jian Liu; Jia Feng; Tingting Bian; Qing Zhang; Jinliang Chen; Xuedong Lv; Jianrong Chen; Yifei Liu
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-06       Impact factor: 4.553

3.  Morin Mitigates Chronic Constriction Injury (CCI)-Induced Peripheral Neuropathy by Inhibiting Oxidative Stress Induced PARP Over-Activation and Neuroinflammation.

Authors:  Prashanth Komirishetty; Aparna Areti; Ramakrishna Sistla; Ashutosh Kumar
Journal:  Neurochem Res       Date:  2016-04-15       Impact factor: 3.996

4.  Translocation Associated Membrane Protein 1 Contributes to Chronic Constriction Injury-Induced Neuropathic Pain in the Dorsal Root Ganglion and Spinal Cord in Rats.

Authors:  Dekun Yin; Yonglin Chen; Rongxiang Lu; Bingbing Fan; Shunxing Zhu; Xingguo Xu; Zhongling Xu
Journal:  J Mol Neurosci       Date:  2018-10-18       Impact factor: 3.444

5.  Overexpression of GRK6 attenuates neuropathic pain via suppression of CXCR2 in rat dorsal root ganglion.

Authors:  Yuan Zhou; Rong-Ji Li; Meng Li; Xuelian Liu; Hong-Yan Zhu; Zhong Ju; Xiuhua Miao; Guang-Yin Xu
Journal:  Mol Pain       Date:  2016-05-04       Impact factor: 3.395

Review 6.  A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists.

Authors:  Kendall L Mores; Benjamin R Cummins; Robert J Cassell; Richard M van Rijn
Journal:  Front Pharmacol       Date:  2019-04-17       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.